Black Box Profit Increased by 30.6% to 72.6 Crore Rupees, Revenue Rose by 22.2%
Read more
Business Standard
business-standard.com

Black Box Profit Increased by 30.6% to 72.6 Crore Rupees, Revenue Rose by 22.2%

The IT company Black Box, part of Essar Group, reported on Friday a 30.6% increase in consolidated net profit, reaching 72.68 crore rupees for the quarter from July to September of fiscal year 27. This growth was driven by the development of business in corporate solutions and data center sectors.

According to the report from the Mumbai-based company, the net profit in the same period last year was 55.65 crore rupees. Black Box's operating revenue increased by 22.2%, amounting to 1,936.30 crore rupees compared to 1,584.59 crore rupees in the second quarter of fiscal year 26. Compared to the previous period, profit and revenue grew by 30% and 13% respectively.

The company stated in its release that the growth was ensured by the successful implementation of projects in the field of hyper-scale data center infrastructure and corporate solutions, as well as by the growing momentum in the technology product business.

Order Information

Furthermore, Black Box secured over $250 million in data center orders in the first half of fiscal year 27. The company noted that a significant portfolio of large deals with hyperscalers should stimulate the acquisition of major orders and accelerate growth in the coming quarters.

As of the end of the quarter in September, the company's total backlog reached $1,044 million, representing an 88% increase compared to the previous year. During this quarter, new contracts totaling $298 million were signed, which is 37% more.

Sanjiv Verma, Managing Director and CEO of Black Box, stated that these results strengthen the company's confidence in scaling the business to achieve the near-term revenue target of $2 billion. He emphasized that the data center business is a powerful growth driver, supported by large orders from numerous hyperscalers and repeated wins in their infrastructure development projects.

Verma added that the company's strong presence in the US, deep expertise, and proven execution capability allow it to capture a larger share in accelerating investments in data centers, which is supported by substantial potential opportunities. He also noted that expanding the business in corporate solutions and technology products in the US and international markets strengthens the growth forecast.

The company expressed confidence in achieving the fiscal year 27 forecast for revenue growth within 23–27% and an increase in after-tax profit of 38–50%, expecting profit growth to remain in high double digits over the next few years alongside strengthened cash generation. The company plans to end the year with a backlog of $1.3–1.4 billion.

The company is also progressing with a plan to hire nearly 3,000 specialists by fiscal year 30, primarily in the US, with recruitment focused on large data center projects.

Similar stories

Divi's Labs profit increased by 64% to 1,127 billion rupees due to revenue growth
Read more
business-standard.com

Divi's Labs profit increased by 64% to 1,127 billion rupees due to revenue growth

Divi's Laboratories Ltd announced a significant increase in net profit of 63.57 percent, reaching 1,127 billion rupees in the September quarter, which was driven by increased revenues.

According to regulatory filings, in the corresponding period last fiscal year, the company earned a net profit of 689 billion rupees. Operating revenue increased by 35.39 percent, amounting to 3,676 billion rupees in the second quarter of fiscal year 27, compared to 2,715 billion rupees the previous year.

During the period under review, the company's total expenses rose to 2,265 billion rupees, whereas they were 1,948 billion rupees a year ago. Nevertheless, the company's net profit for the first half of the current fiscal year decreased by 35.39 percent, totaling 2,029 billion rupees compared to 2,568 billion rupees in the same period last year.

Dr Lal PathLabs' profit grew by 27.5% in the second quarter to 194 crore rupees due to volume growth
Read more
business-standard.com

Dr Lal PathLabs' profit grew by 27.5% in the second quarter to 194 crore rupees due to volume growth

Dr Lal PathLabs, a major diagnostic operator based in Delhi, reported a 27.5% year-on-year growth in consolidated net profit for the September quarter (Q2) of the fiscal year 2026-27 (FY27). This growth was achieved through an increase in testing revenues.

The company's net profit in Q2 FY27 amounted to 194 crore rupees, which is higher than the 152 crore rupees recorded during the same period last year. The main driver of this growth was the increase in sample volumes, which rose by 13.6% year-on-year to reach 28.8 million.

Furthermore, patient coverage in the network increased by 9% year-on-year, reaching 9 million in September, compared to 8.2 million in the same period the previous year. Consequently, the network's revenue increased by 19.6% year-on-year, reaching 874 crore rupees compared to 731 crore rupees in Q2 FY26.

Shankha Banerjee, CEO of DLPL, noted that there is a growing demand for high-complexity testing and specialized analyses, supported by increased awareness among doctors and patients. Operationally, the EBITDA margin increased by 25%, reaching 280 crore rupees from 224 crore rupees, and the EBITDA margin improved to 32.1% from 30.7%.

He also added that the company's future focus will be on expanding access to advanced diagnostics by strengthening capabilities in areas such as genomics, oncology, reproductive health, transplant diagnostics, and rare diseases.

As of September 30, 2026, DLPL, the largest provider of diagnostic services in India, operates 312 clinical laboratories, including the national reference laboratory in Delhi and regional reference laboratories in Kolkata, Bengaluru, and Mumbai. The network also includes 7,727 Patient Service Centers (PSC) and 13,935 Pickup Points (PUP), serving private patients, hospitals, healthcare professionals, and corporate clients.

DLPL's board of directors also approved an additional investment of up to 49.5 crore rupees in its wholly-owned subsidiary in Dubai, Dr Lal PathLabs FZCO, to meet its business and operational needs. In regulatory filings, DLPL indicated that this subsidiary will make further investments in its subsidiary Sunshine Healthcare Limited (SHL) in Ghana.

The results were announced during market trading. DLPL shares closed on the BSE on Wednesday 5.1% higher, at a price of 2,028.95 rupees per share.

Popular